Side by side: size, value over time, results, valuation, margins, growth, debt and shareholder returns, and any of thirty figures charted over the years (up to 6).
Open these as a peer group: up to 12 companies with suggested peers, each company's rank in the group and percentile in its sector and country, saved for you or your team.
From Jan 2020: how each company's value moved, whatever its size.
US$ billions, as reported in each year's annual results.
Not enough data yet.
Revenue of the fiscal year. US dollars at each year's exchange rate.
| Measure | AS Grindeks✕ GRD1R.RG | As Olainfarm✕ UU4.F |
|---|---|---|
| Profile | ||
| Country | 🇱🇻 Latvia | 🇱🇻 Latvia |
| Sector | Healthcare | Healthcare |
| Industry | — | Pharmaceutical |
| Founded | — | 1991 |
| Size | ||
| Revenue | — | |
The largest companies, each against its nearest peers in value from the same industry.
Fewer than two years of revenue are on file for these companies.
| Fiscal year | AS Grindeks | As Olainfarm |
|---|---|---|
| 2022 | — | $119 MWD |
Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports; Ed. = the company's report (editors); WD = Wikidata, citing the annual report; Cap = value.today market caps. Hover a figure for its period.
| $119 M |
| Net income | — | $19 M |
|---|
| Employees | — | 1,054 |
|---|
| Altman Z-score zone | — | — |
|---|
| Data as of | Market cap Jan 2021 | Market cap Jan 2021 |
|---|
Market caps from exchange data or SEC filings on the date shown (* last known value, no current one); revenue and net income from the latest annual results; ratios worked out from each company's own statements for the fiscal year shown. ▲ marks the best of these companies where higher or lower is better; size and valuation multiples are marked for no one. Definitions: methodology.